We are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.
$15.00 - $17.00
June 28, 2019
GOLDMAN SACHS & CO. LLC ,CITIGROUP GLOBAL MARKETS INC.,WELLS FARGO SECURITIES, LLC
To view the prospectus for Karuna Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253